Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...

The Autism Diagnostic Interview-Revised (ADI-R) is one of the most widely used and thoroughly researched caregiver interview ...

Cloudflare has set a 2029 deadline for full post-quantum security, prioritizing authentication over encryption to counter ...

This year’s event reflected an appliance and consumer electronics sector caught between rapid product iteration and a broader market reset, including the deeper integration of artificial intelligence ...

Artificial wombs are recreating pregnancy outside the body, keeping premature life developing in controlled environments.

Google published a research blog post on Tuesday about a new compression algorithm for AI models. Within hours, memory stocks were falling. Micron dropped 3 per cent, Western Digital lost 4.7 per cent ...

CS Ministry of Investments, Trade and Industry Lee Kinyanjui speaks at the 5th Economic and Sustainability Forum. [Wilberforce Okwiri, Standard] The government plans to intensify value addition and ...

Organizations of all sizes in all industries face a monumental project of migrating to post-quantum cryptography (PQC) to address the risk of adversaries using quantum computing to intercept sensitive ...

Jay Soneff has spent his career navigating real estate cycles — booms that feel unstoppable and downturns that expose who’s built to last. A third-generation Denver native and longtime commercial real ...

LinkedIn's algorithm has changed, making old tactics obsolete. Align your profile with content topics. Prioritize "saves" as the key engagement metric by creating valuable, referenceable content. Post ...

ABSTRACT: Purpose: Biomechanical evidence indicates that enhanced coordination in the proximal-to-distal kinetic chain contributes to smash performance in badminton players. Functional training ...

Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) delayed disease progression in patients with HER2-positive metastatic breast cancer, ...